Riskpilot← Back to searchSign inGet full accessHAMMERFEST APOTEK AS
ASActiveOrg 984700636Strandgata 8, 9600 HammerfestRetail sale of pharmaceutical products · NACE 4773Est. 20020 employeeswww.apotek1.no
Revenue 2021
NOK 32,2M
+7% vs 2020
EBITDA margin
2.4%
-11% vs 2020
Equity ratio
8.9%
Financial strength
Net profit 2021
NOK 612K
-12% vs 2020
| Revenue | NOK 32,2M | +7% |
| EBITDA | NOK 776K | -11% |
| Net profit | NOK 612K | -12% |
| Total assets | NOK 11,2M | +32% |
| Equity | NOK 991K | +1% |
| Employees | 0 | — |
Legal name
HAMMERFEST APOTEK AS
Org number
984700636
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
14. september 2002
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-01-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Apotekdrift, handel og det som naturlig hører inn under dette.
Address
Strandgata 8, 9600 Hammerfest
Website
www.apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 28 242 | 28 753 | 28 747 | 30 101 | 32 230 |
| Staff expenses | −4 632 | −4 607 | −4 952 | −4 645 | −5 055 |
| EBITDA | 879 | 821 | 479 | 873 | 776 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 879 | 821 | 479 | 873 | 776 |
| Net financials | 9 | 6 | 11 | 21 | 10 |
| Profit before tax | 888 | 826 | 490 | 894 | 786 |
| Tax | 219 | 194 | 113 | 201 | 174 |
| Net profit | 670 | 632 | 377 | 693 | 612 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 9 873 | 8 036 | 8 076 | 8 429 | 11 152 |
| Equity | 877 | 909 | 887 | 980 | 991 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 996 | 7 127 | 7 189 | 7 449 | 10 160 |
| Total debt | 8 996 | 7 127 | 7 189 | 7 449 | 10 160 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20172021
Equity ratio
8.9%
This company
38.2%
Market median
-77% vs market
20172021
Return on equity
61.7%
This company
18.4%
Market median
+235% vs market
20172021
Net profit margin
1.9%
This company
8.1%
Market median
-77% vs market
20172021
Asset turnover
2.89×
This company
1.12×
Market median
+158% vs market
20172021
Debt / equity
10.25×
This company
0.62×
Market median
-1553% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-02-01 – 2020-01-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-02-01 – 2019-01-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-02-01 – 2018-01-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2016-02-01 – 2017-01-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HH Chief Executive Officer | Chief Executive Officer | 2021 |
IJ Deputy Member | Deputy Member | 2003 |
| Former (1) | ||
MN Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2003 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HAMMERFEST APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håkon Hanssen Nestande | Chief Executive Officer | 0 companies |
| Inger Johanne Kristensen | Deputy Member | 0 companies |
| Mona Nilsen | Chief Executive Officer | 0 companies |
| Hege Hillestad | Chairman | 0 companies |